Board of Directors
Mr Tommie CE Bergman
ChairmanAge 61. DipEng, Grad DipMarketing, FAICD, FAIM
Appointed Chairman 22 October 2002.
Appointed director and Deputy Chairman 1 January 2002.
Director of Smorgon Steel Group Limited since 1999. Member of Advisory Board of Caliburn Partnership Pty Ltd. Former Chairman (2003 – 2005) and Deputy Chairman (2001 – 2002) of WMC Resources Limited and director of Amcor Limited (1997 – 2003) and Atlas Copco Australia Pty Ltd. Former Chairman and Managing Director of Asea Brown Boveri Australasia Pty Ltd (1991 – 2002). Prior to that held CEO and Chairman positions in the ABB Group in Singapore, India, Portugal and the United States.
Chairman of the Nominations Committee. Member of the Audit Committee and Remuneration Committee.
Dr. Chris Roberts
CEO/PresidentAge 52. BE (Hons), MBA, PhD, FAICD, FTSE
Appointed 1 February 2004
Chief Executive Officer of Cochlear Limited. Director of ResMed Inc since 1992 and Chairman of Research Australia. Dr Roberts has worked in the medical device industry for more than 30 years in a number of senior management positions.
Member of the Medical Science Committee and Technology and Innovation Committee.
Mr Paul R Bell
Age 61. BA, MA (Hons)Appointed 1 August 2005
Director of Bio-Link Partners Limited since 2005 and GroPep Limited since 2003. Extensive executive career spanning 30 years with the international pharmaceutical company, Merck & Co Inc (Managing Director – Australia, 1988 – 1997; President of the Asia Pacific Human Health Division, 1997– 2002). Member of the Global Merck Management Committee.
Chairman of the Remuneration Committee. Member of the Nominations Committee and Technology and Innovation Committee.
Prof Edward Byrne, AO
Age 55. DSc, MD, MBA, FRCP, FRACPAppointed 1 July 2002
Dean of Faculty of Medicine, Nursing and Health Sciences at Monash University, Melbourne, Deputy Chair of Neurosciences Victoria Limited. Director of Neurosciences Australia Limited. Board member of the Baker Medical Research Institute, Burnet Medical Research Institute, Prince Henry’s Medical Research Institute, Southern Health and Mental Health Research Institute.
Chairman of the Medical Science Committee. Member of the Nominations Committee and Technology and Innovation Committee.
Mr Andrew Denver
Age 58. BSc (Hons) MBA, FAICDAppointed 1 February 2007
Director of CathRx Limited, chariman of Universal Biosensor Pty Ltd and a director of the Principals Funds Management Pty Ltd. Former managing director of Memtec Limited and President Asia for Pall Corporation.
Member of the Audit Committee, Nominations Committee and Technology & Innovation Committee.
Mr Rick Holliday-Smith
Age 57. BA (Hons), FAICDAppointed 1 March 2005
Chairman of SFE Corporation Limited since 1999 until de-listing in July 2006. Director of DCA Group Limited since 2004, MIA Group Limited (2000 – 2004) until acquired by DCA Group Limited, Servcorp Limited since 1999 and ASX Limited since July 2006. Chairman of Snowy Hydro Limited (not listed) since May 2006. Former director of Exco Resources NL (1999 – 2006). Former President of NationsBank-CRT, Chicago and Managing Director of Hong Kong Bank Limited, London.
Chairman of the Audit Committee. Member of the Nominations Committee and Remuneration Committee.
Mr Donal P O'Dwyer
Age 53. BECivil, MBAAppointed 1 August 2005
President of Cordis Cardiology (Johnson & Johnson medical device business unit with annual turnover of over USD 2 billion) between 2000 and 2004. Chairman of Atcor Medical since 2004 and a director of Sunshine Heart Inc since 2004, Mesoblast Limited since 2004 and Angioblast Systems Inc since 2005.
Member of the Medical Science Committee, Nominations Committee and Technology and Innovation Committee.
